News | June 17, 2023
MoS Health addresses TB Health Technologies workshop
Urges Innovators to produce quality products that can be deployed at scale
Urges Innovators to produce quality products that can be deployed at scale
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
Acuitas Therapeutics' LNP technology will support Bayer’s in vivo gene editing and protein replacement programs with the goal of specifically delivering RNA payloads to the desired target organ, the liver.
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Subscribe To Our Newsletter & Stay Updated
